Variant report
Variant | esv3391964 |
---|---|
Chromosome Location | chr1:196063229-196066527 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75418097 | chr1:196064026-196064027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573104985 | chr1:196064040-196064041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs111888727 | chr1:196064041-196064042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79612948 | chr1:196064053-196064054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79617277 | chr1:196064054-196064055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183889792 | chr1:196064063-196064064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs547334290 | chr1:196064093-196064094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565617119 | chr1:196064120-196064121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188469693 | chr1:196064135-196064136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569418516 | chr1:196064184-196064185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs34163247 | chr1:196064217-196064218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs72746198 | chr1:196064232-196064233 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs201704986 | chr1:196064247-196064248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143326721 | chr1:196064322-196064323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558894797 | chr1:196064327-196064328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571065489 | chr1:196064331-196064332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs181022684 | chr1:196064332-196064333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72746199 | chr1:196064385-196064386 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs184299252 | chr1:196064389-196064390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539827263 | chr1:196064418-196064419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542268398 | chr1:196064446-196064447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561386331 | chr1:196064468-196064469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113795274 | chr1:196064481-196064482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146700067 | chr1:196064483-196064484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190815860 | chr1:196064499-196064500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564420938 | chr1:196064534-196064535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140273373 | chr1:196064801-196064802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181920328 | chr1:196064822-196064823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559238889 | chr1:196064824-196064825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186126304 | chr1:196064840-196064841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114565110 | chr1:196064844-196064845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569592884 | chr1:196064851-196064852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368107309 | chr1:196064852-196064853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530414423 | chr1:196064886-196064887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552293442 | chr1:196064894-196064895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570428712 | chr1:196064899-196064900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573231283 | chr1:196064907-196064908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535264876 | chr1:196064909-196064910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190496730 | chr1:196065151-196065152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553567515 | chr1:196065214-196065215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568774883 | chr1:196065282-196065283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs77060064 | chr1:196065305-196065306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542871835 | chr1:196065309-196065310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536117258 | chr1:196065331-196065332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557364485 | chr1:196065352-196065353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181346099 | chr1:196065361-196065362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545856023 | chr1:196065401-196065402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs143461215 | chr1:196065445-196065446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34163163 | chr1:196065480-196065481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs61822065 | chr1:196065507-196065508 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 21062444 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Neuroblastoma | 20406844 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:196064000-196064200 | Enhancers | Fetal Stomach | stomach |
2 | chr1:196064200-196065600 | Weak transcription | Fetal Stomach | stomach |
3 | chr1:196065600-196065800 | Enhancers | Fetal Stomach | stomach |
4 | chr1:196065600-196067600 | Enhancers | Fetal Lung | lung |
5 | chr1:196065800-196066600 | Weak transcription | Fetal Stomach | stomach |
6 | chr1:196066000-196067400 | Enhancers | Brain Hippocampus Middle | brain |
7 | chr1:196066000-196067600 | Enhancers | Brain Inferior Temporal Lobe | brain |
8 | chr1:196066200-196068200 | Enhancers | Brain Cingulate Gyrus | brain |
9 | chr1:196066400-196067000 | Enhancers | Brain Germinal Matrix | brain |
10 | chr1:196066400-196067200 | Enhancers | Brain Angular Gyrus | brain |
11 | chr1:196066400-196067600 | Enhancers | Brain Substantia Nigra | brain |
12 | chr1:196066400-196067800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |